Menu
GeneBe

rs77573084

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2

The NM_005548.3(KARS1):c.1258C>T(p.Arg420Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00292 in 1,613,744 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R420H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0019 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0030 ( 11 hom. )

Consequence

KARS1
NM_005548.3 missense

Scores

6
6
5

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 10.0
Variant links:
Genes affected
KARS1 (HGNC:6215): (lysyl-tRNA synthetase 1) Aminoacyl-tRNA synthetases are a class of enzymes that charge tRNAs with their cognate amino acids. Lysyl-tRNA synthetase is a homodimer localized to the cytoplasm which belongs to the class II family of tRNA synthetases. It has been shown to be a target of autoantibodies in the human autoimmune diseases, polymyositis or dermatomyositis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.10187775).
BP6
Variant 16-75631248-G-A is Benign according to our data. Variant chr16-75631248-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 226679.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-75631248-G-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00193 (294/152282) while in subpopulation NFE AF= 0.00378 (257/68020). AF 95% confidence interval is 0.0034. There are 1 homozygotes in gnomad4. There are 120 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
KARS1NM_005548.3 linkuse as main transcriptc.1258C>T p.Arg420Cys missense_variant 10/14 ENST00000302445.8
KARS1NM_001130089.2 linkuse as main transcriptc.1342C>T p.Arg448Cys missense_variant 11/15
KARS1NM_001378148.1 linkuse as main transcriptc.790C>T p.Arg264Cys missense_variant 10/14

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
KARS1ENST00000302445.8 linkuse as main transcriptc.1258C>T p.Arg420Cys missense_variant 10/141 NM_005548.3 A1Q15046-1
KARS1ENST00000319410.9 linkuse as main transcriptc.1342C>T p.Arg448Cys missense_variant 11/151 P4Q15046-2
KARS1ENST00000568378.5 linkuse as main transcriptc.147-3259C>T intron_variant 5
KARS1ENST00000564578.5 linkuse as main transcriptc.*801C>T 3_prime_UTR_variant, NMD_transcript_variant 10/145

Frequencies

GnomAD3 genomes
AF:
0.00193
AC:
294
AN:
152164
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000700
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000458
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00378
Gnomad OTH
AF:
0.000479
GnomAD3 exomes
AF:
0.00149
AC:
374
AN:
250636
Hom.:
2
AF XY:
0.00154
AC XY:
209
AN XY:
135536
show subpopulations
Gnomad AFR exome
AF:
0.000494
Gnomad AMR exome
AF:
0.000377
Gnomad ASJ exome
AF:
0.0000996
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00306
Gnomad OTH exome
AF:
0.000653
GnomAD4 exome
AF:
0.00302
AC:
4413
AN:
1461462
Hom.:
11
Cov.:
32
AF XY:
0.00290
AC XY:
2111
AN XY:
727044
show subpopulations
Gnomad4 AFR exome
AF:
0.000777
Gnomad4 AMR exome
AF:
0.000515
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0000562
Gnomad4 NFE exome
AF:
0.00376
Gnomad4 OTH exome
AF:
0.00306
GnomAD4 genome
AF:
0.00193
AC:
294
AN:
152282
Hom.:
1
Cov.:
33
AF XY:
0.00161
AC XY:
120
AN XY:
74456
show subpopulations
Gnomad4 AFR
AF:
0.000698
Gnomad4 AMR
AF:
0.000458
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00378
Gnomad4 OTH
AF:
0.000474
Alfa
AF:
0.00304
Hom.:
4
Bravo
AF:
0.00208
TwinsUK
AF:
0.00378
AC:
14
ALSPAC
AF:
0.00337
AC:
13
ESP6500AA
AF:
0.000910
AC:
4
ESP6500EA
AF:
0.00302
AC:
26
ExAC
AF:
0.00133
AC:
162
EpiCase
AF:
0.00300
EpiControl
AF:
0.00297

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Likely benign, criteria provided, single submitterclinical testingInvitaeJan 22, 2024- -
Likely benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesOct 14, 2023- -
Likely benign, criteria provided, single submitterclinical testingGeneDxDec 09, 2020This variant is associated with the following publications: (PMID: 26762739) -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenAug 01, 2023KARS1: BS2 -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineNov 24, 2014Arg448Cys in exon 11 of KARS: This variant is not expected to have clinical sign ificance because it has been identified in 0.3% (26/8600) of European American c hromosomes from a broad population by the NHLBI Exome Sequencing Project (http:/ /evs.gs.washington.edu/EVS; dbSNP rs77573084). -
KARS1-related disorder Benign:1
Likely benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesFeb 11, 2022This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Uncertain
0.060
T
BayesDel_noAF
Pathogenic
0.31
Cadd
Pathogenic
31
Dann
Uncertain
1.0
Eigen
Pathogenic
0.69
Eigen_PC
Pathogenic
0.76
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.90
D;D
M_CAP
Uncertain
0.13
D
MetaRNN
Benign
0.10
T;T
MetaSVM
Uncertain
0.15
D
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Uncertain
0.64
T
PROVEAN
Pathogenic
-4.5
D;D
REVEL
Pathogenic
0.68
Sift
Benign
0.12
T;T
Sift4G
Benign
0.16
T;T
Polyphen
0.42
B;D
Vest4
0.87
MVP
0.91
MPC
0.55
ClinPred
0.075
T
GERP RS
5.9
Varity_R
0.78
gMVP
0.82

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs77573084; hg19: chr16-75665146; COSMIC: COSV56692206; COSMIC: COSV56692206; API